Astaxanthin for Prediabetes: What Does the Research Show?

Prediabetes develops when blood glucose levels rise above the healthy range but have not yet reached the threshold used to diagnose type 2 diabetes. At this stage, the body can become less responsive to insulin, making it more difficult to move glucose from the bloodstream into cells.

Research into nutritional strategies for metabolic health has drawn attention to astaxanthin, a naturally occurring carotenoid known for its antioxidant properties. Emerging clinical evidence suggests that astaxanthin can support several areas relevant to prediabetes, including glucose metabolism, insulin sensitivity, cholesterol balance and vascular function.

Supporting the Body’s Response to Glucose

One of the most relevant clinical trials examined the effects of astaxanthin in healthy adults, including participants with prediabetes. In this randomized, placebo-controlled study, participants received either 12 mg of astaxanthin or a placebo once daily for 12 weeks.

Researchers assessed glucose metabolism using a 75 g oral glucose tolerance test. This test measures how the body manages a concentrated dose of glucose over time.

After 12 weeks, participants taking astaxanthin had lower glucose levels 120 minutes after the test compared with their levels before supplementation. Their insulin levels at the same time point also decreased. These results suggest that the body required less circulating insulin while managing glucose during the later phase of the test.

A related analysis focused on 29 participants whose initial HbA1c levels ranged from 5.6% to 6.4%, a range that included people with elevated blood glucose and prediabetes. After taking 12 mg of astaxanthin daily for 12 weeks, participants showed an improvement in glucose levels measured 30 minutes after the glucose tolerance test.

Together, these findings indicate that astaxanthin can support the way the body handles glucose after a carbohydrate challenge.

Astaxanthin and Insulin Sensitivity

Insulin sensitivity describes how effectively the body’s tissues respond to insulin. When insulin sensitivity declines, the pancreas must release more insulin to manage the same amount of glucose. This process is a central feature of prediabetes.

In the 12-week clinical trial, researchers measured insulin sensitivity using the Matsuda index, which evaluates insulin action using glucose and insulin measurements collected during an oral glucose tolerance test.

The Matsuda index improved following astaxanthin supplementation, suggesting better whole-body insulin sensitivity. The earlier subgroup analysis also reported improvement in an index of hepatic insulin resistance, indicating that astaxanthin can support the liver’s response to insulin.

This is especially relevant because the liver helps regulate blood glucose between meals. When hepatic insulin sensitivity improves, the liver can respond more effectively to insulin signals and better control the release of stored glucose into the bloodstream.

Potential Support for HbA1c

HbA1c reflects average blood glucose over approximately two to three months. It is commonly used to identify and monitor prediabetes and diabetes.

In the clinical trial, average HbA1c decreased from 5.64% to 5.57% after 12 weeks of astaxanthin supplementation. Although the change was modest, it suggests that astaxanthin can contribute to healthier long-term glucose regulation.

Broader evidence also supports this possibility. A 2026 meta-analysis combined nine randomized controlled trials involving 403 adults with prediabetes or type 2 diabetes. Across the included studies, astaxanthin supplementation was associated with average reductions of approximately 16.1 mg/dL in fasting blood glucose and 0.34 percentage points in HbA1c compared with control treatments.

The studies varied in participant characteristics, doses and intervention periods, so individual responses can differ. However, the overall findings support continued interest in astaxanthin as part of a broader metabolic-health strategy.

Supporting a Healthier Lipid Profile

Prediabetes can affect more than blood glucose. It commonly occurs alongside changes in triglycerides, LDL cholesterol and HDL cholesterol, which can influence long-term cardiovascular health.

The 2026 meta-analysis found that astaxanthin supplementation was associated with:

• Lower triglyceride levels

• Lower total cholesterol

• Lower LDL cholesterol

• Higher HDL cholesterol

The pooled changes included an average triglyceride reduction of approximately 20.9 mg/dL, an LDL cholesterol reduction of about 9.4 mg/dL and an HDL cholesterol increase of around 3 mg/dL.

These findings suggest that astaxanthin can provide support across several interconnected areas of metabolic health rather than influencing glucose regulation alone.

Protecting LDL From Oxidative Modification

The quality of circulating LDL particles is also important. When LDL becomes oxidatively modified, it can interact differently with blood-vessel walls and contribute to processes associated with atherosclerosis.

In the 12-week trial, astaxanthin reduced malondialdehyde-modified LDL, a laboratory marker of oxidatively altered LDL. Apolipoprotein E levels also decreased.

Because astaxanthin functions as an antioxidant, these changes suggest one possible way it can support cardiovascular health in people experiencing early metabolic changes.

Astaxanthin and Vascular Function

Healthy blood vessels must expand and contract in response to changes in blood flow. This process depends partly on the endothelium, the thin cellular layer lining the inside of blood vessels.

The clinical trial measured endothelial function using the reactive hyperemia index. This measurement improved after astaxanthin supplementation, indicating healthier blood-vessel responsiveness.

Supporting endothelial function is relevant to prediabetes because elevated glucose, inflammation and oxidative stress can place additional pressure on the vascular system.

A Complementary Approach to Prediabetes Management

Current evidence suggests that astaxanthin can support several biological processes relevant to prediabetes:

• Glucose handling after carbohydrate intake

• Whole-body and liver insulin sensitivity

• Fasting glucose and HbA1c

• Triglyceride and cholesterol balance

• Protection against oxidative modification of LDL

• Healthy endothelial function

Astaxanthin should be viewed as a complementary nutritional option rather than a substitute for established prediabetes management. Balanced nutrition, regular physical activity, healthy sleep, weight management when appropriate and professional monitoring remain central to improving metabolic health.

For people interested in antioxidant support, however, astaxanthin offers a promising combination of metabolic and cardiovascular benefits. The available clinical evidence indicates that its potential extends beyond antioxidant activity alone, with measurable effects on how the body processes glucose, responds to insulin and maintains healthy blood vessels.